Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic epidural spinal cord compression: update on management.

Thomas N Byrne1, Lawrence F Borges, Jay S Loeffler

  • 1Department of Neurology and Health Sciences Technology, Harvard Medical School and Massachusetts General Hospital, Boston, 02114, USA. tnbyrne@mit.edu

Seminars in Oncology
|June 14, 2006
PubMed
Summary

Metastatic epidural spinal cord compression (MESCC) management has evolved beyond routine corticosteroids and radiotherapy. Advances in imaging, prognostics, and surgical techniques necessitate individualized treatment plans for MESCC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal Cord Ependymomas.

Neurosurgery clinics of North America·2026
Same author

Resolution of pachymeningeal enhancement is a radiographic marker for effective treatment of spontaneous intracranial hypotension: patient series.

Journal of neurosurgery. Case lessons·2026
Same author

ROCK-dependent mechanotransduction of macroscale forces drives fibrosis in degenerative spinal disease.

Nature biomedical engineering·2025
Same author

Role of RPA Phosphorylation in the ATR-Dependent G2 Cell Cycle Checkpoint.

Genes·2023
Same author

Abnormal bolus reflux on impedance-pH testing independently predicts 3-year pulmonary outcome and mortality in pulmonary fibrosis.

Journal of gastroenterology and hepatology·2023
Same author

Health-related quality of life analyses in nonfunctioning pituitary macroadenoma patients identifies at-risk populations.

Pituitary·2023

Area of Science:

  • Oncology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Metastatic epidural spinal cord compression (MESCC) traditionally managed with corticosteroids and radiotherapy (RT).
  • Significant advancements in medical technology and understanding have altered the treatment landscape for MESCC.
  • The need for personalized treatment strategies is increasingly recognized.

Purpose of the Study:

  • To review recent advances in the management of MESCC.
  • To highlight key developments in imaging, prognostic factors, and therapeutic techniques (RT and surgery).
  • To advocate for an individualized approach to MESCC patient care.

Main Methods:

  • Historical review of MESCC management.
  • Discussion of recent technological and clinical advancements.

Related Experiment Videos

  • Synthesis of current evidence to support personalized treatment.

    • Main Results:

    • Imaging improvements offer better visualization and diagnosis of MESCC.
    • Identification of new prognostic factors aids in risk stratification.
    • Novel RT and surgical techniques provide expanded therapeutic options.

    Conclusions:

    • Modern MESCC management requires a multidisciplinary and individualized approach.
    • Treatment decisions should integrate patient-specific factors with recent therapeutic innovations.
    • Continued research and adaptation of techniques are crucial for optimizing outcomes in MESCC.